What's New
11/09/2023 – Melanoma Risk in the Military Community
11/08/2023 – Navy Veteran Ashlynn Soellner's Melanoma Journey
10/13/2023 – MRA Statement on Expanded Approval of Nivolumab to Patients with Stage 2 Disease
09/30/2023 – A Message from Our CEO on Rare Cancer Day
09/20/2023 – Thriving after Advanced Melanoma at 26: John Elson’s Story